Recently, researches have demonstrated that S100A8 and S100A9 dimers could interact with multiple receptors like RAGE (receptor for advanced glycation end products), TLR (toll-like receptor) and Wnt/β-catenin to promote tumor developments and invasiveness 58-60. The gene discussed is S100A8; the disease is neoplasm.